Therapeutic effect of (E)-5-(2-bromoviny
β
Dr. Bjorn Helbig; Andreas Sauerbrei; Renate KlΓΆcking; Peter Wutzler; Norbert Wic
π
Article
π
1987
π
John Wiley and Sons
π
English
β 383 KB
The influence of (E)-5-(2-bromovinyl)-2'-de~xyuridine (BVDU), caffeic acid oxidation product (KOP), and trisodiumphosphonoformate (TPF) on the course of the primary cutaneous herpes simplex virus infection was investigated by means of a guinea pig test model. The antiviral substances were applied in